About Manisha Chatterjee
Since she was young, Manisha has had a strong interest in the stock market. She majored in Economics in college and has a passion for writing, which has led to her career as a research analyst.
Manisha’s goal is to help individual investors succeed in the stock market. She uses her knowledge in fundamental analysis to evaluate companies and determine if they are worthwhile investments.
Recent Articles By Manisha Chatterjee
3 Hospital Stocks to Buy as COVID-19 Cases Rise
Hospitals are again witnessing increasing demand for their services as the COVID-19 Delta variant spreads around the world at a rapid pace. So, we think it could be wise to now scoop up shares of quality hospital stocks Tenet Healthcare (THC), Encompass Health (EHC), and Select Medical Holdings (SEM).
Down More Than 30% in the Past 3 Months, is Now a Good Time to Scoop Up Shares of Skillz?
Shares of Skillz (SKLZ) have declined 33.5% in price over the past three months due to investors’ pessimism surrounding a lawsuit it is facing, among other factors. Nevertheless, the company reported its 22nd consecutive quarter of growth in its latest quarter. So, let’s find out if it is wise to buy SKLZ shares now on their dip in price.
Is Cano Health a Good Healthcare Stock to Invest In?
Cano Health (CANO) is a lesser-known company in the healthcare space that reported impressive financials for its first quarter as a publicly traded company. But can the stock gain in the coming quarters despite investor pessimism surrounding SPACs? Read on.
3 Top AI Stocks to Buy Right Now
While artificial intelligence (AI) has already transformed how many companies work, it is expected to make further advancements that rely on machine learning and deep learning, among other factors. So, we think it could be wise to bet on top AI stocks Intel (INTC), International Business Machines (IBM), and Micron (MU), amid the fast-paced digital transformation. Read on.
Up More Than 35% in the Past 3 Months, Will DoorDash Continue to Climb?
DoorDash’s (DASH) shares have soared 38.3% in price over the past three months on investors’ optimism surrounding its expansion into Japan and its strategic partnerships. But can the stock continue rallying despite the company reporting a wider-than-expected loss in the second quarter? Let’s find out.
2 Biotech Stocks Focused on Fighting the Coronavirus that Could Double in Price
As the rapid spread of the COVID-19 Delta variant continues to disrupt several economies, there is growing concern about the virus’ potential long-term physical effects. Given this backdrop, which suggests more therapies will need to be developed, we think it could be wise to investigate biotech stocks Humanigen (HGEN) and AIM ImmunoTech (AIM) because Wall Street analysts expect them to double in price in the coming months. Read on.
Is fuboTV a Buy Under $30?
Shares of fuboTV (FUBO) are currently trading at a considerable discount to their $62.29 all-time high, which they hit in December 2020. So, can the expected launch of Fubo Sportsbook in the fourth quarter help the stock rebound? Let’s find out.
3 A-Rated Stocks Under $10 to Buy Right Now
While it’s not easy to find quality low-priced stocks in the current, expensive stock market, shares of Tile Shop (TTSH), Lincoln Educational Services (LINC), and Huttig Building Products (HBP) are currently trading at less than $10, and we think they still have plenty of upside to deliver. Each of these stocks has an overall A (Strong Buy) rating in our proprietary rating system. So, let’s examine these names.
Annaly Capital Management vs. Granite Point: Which Mortgage REIT is a Better Choice?
With income investors looking to invest in high dividend-yielding mortgage REITs amid the near-zero interest rate environment, both Annaly Capital Management (NLY) and Granite Point (GPMT) could attract significant attention. But which of these stocks is a better buy now? Read more to find out.